These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18045666)

  • 1. Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma.
    Connolly GC; Chen R; Hyrien O; Mantry P; Bozorgzadeh A; Abt P; Khorana AA
    Thromb Res; 2008; 122(3):299-306. PubMed ID: 18045666
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Abouchaleh N; Gabr A; Ali R; Al Asadi A; Mora RA; Kallini JR; Mouli S; Riaz A; Lewandowski RJ; Salem R
    J Nucl Med; 2018 Jul; 59(7):1042-1048. PubMed ID: 29217739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
    Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
    Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal Vein Thrombosis and Markers of Inflammation in Hepatocellular Carcinoma.
    Carr BI; Guerra V; Donghia R
    J Gastrointest Cancer; 2020 Dec; 51(4):1141-1147. PubMed ID: 32851544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Presence of Portal Vein Thrombosis Alters the Classic Enhancement Associated with Diagnosis of Hepatocellular Carcinoma.
    Umar NK; Badshah MB; Sandrasegaran K; Ghabril M; Agarwal S; Tann M; Lacerda M; Kwo PY
    Dig Dis Sci; 2015 Jul; 60(7):2196-200. PubMed ID: 25777258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A-VENA Criteria.
    Sherman CB; Behr S; Dodge JL; Roberts JP; Yao FY; Mehta N
    Liver Transpl; 2019 Feb; 25(2):207-216. PubMed ID: 30246323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression.
    Memon K; Kulik L; Lewandowski RJ; Mulcahy MF; Benson AB; Ganger D; Riaz A; Gupta R; Vouche M; Gates VL; Miller FH; Omary RA; Salem R
    J Hepatol; 2013 Jan; 58(1):73-80. PubMed ID: 23000237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients.
    Khoury T; Massarwa M; Hazou W; Daher S; Hakimian D; Benson AA; Ashqar T; Mahamid M; Yaari S
    J Gastrointest Cancer; 2019 Dec; 50(4):759-762. PubMed ID: 30043228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival.
    Somma F; Stoia V; Serra N; D'Angelo R; Gatta G; Fiore F
    PLoS One; 2019; 14(5):e0216935. PubMed ID: 31141552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres.
    Biederman DM; Titano JJ; Tabori NE; Pierobon ES; Alshebeeb K; Schwartz M; Facciuto ME; Gunasekaran G; Florman S; Fischman AM; Patel RS; Nowakowski FS; Kim E
    J Vasc Interv Radiol; 2016 Jun; 27(6):812-821.e2. PubMed ID: 27062356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
    Carr BI; Guerra V
    Dig Dis Sci; 2016 Mar; 61(3):937-47. PubMed ID: 26576554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
    Garin E; Rolland Y; Edeline J; Icard N; Lenoir L; Laffont S; Mesbah H; Breton M; Sulpice L; Boudjema K; Rohou T; Raoul JL; Clement B; Boucher E
    J Nucl Med; 2015 Mar; 56(3):339-46. PubMed ID: 25678490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis.
    Han ML; Chen CC; Kuo SH; Hsu WF; Liou JM; Wu MS; Wang HP
    J Gastroenterol Hepatol; 2014 Feb; 29(2):344-51. PubMed ID: 23870023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis.
    Silva JP; Berger NG; Tsai S; Christians KK; Clarke CN; Mogal H; White S; Rilling W; Gamblin TC
    HPB (Oxford); 2017 Aug; 19(8):659-666. PubMed ID: 28552299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma.
    Zanetto A; Senzolo M; Vitale A; Cillo U; Radu C; Sartorello F; Spiezia L; Campello E; Rodriguez-Castro K; Ferrarese A; Farinati F; Burra P; Simioni P
    Dig Liver Dis; 2017 Apr; 49(4):440-445. PubMed ID: 28109767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.
    Kulik LM; Carr BI; Mulcahy MF; Lewandowski RJ; Atassi B; Ryu RK; Sato KT; Benson A; Nemcek AA; Gates VL; Abecassis M; Omary RA; Salem R
    Hepatology; 2008 Jan; 47(1):71-81. PubMed ID: 18027884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients.
    Faccia M; Santopaolo F; Gasbarrini A; Pompili M; Zocco MA; Ponziani FR
    Intern Emerg Med; 2022 Aug; 17(5):1327-1334. PubMed ID: 35076898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.
    Yaprak O; Akyildiz M; Dayangac M; Demirbas BT; Guler N; Dogusoy GB; Yuzer Y; Tokat Y
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):256-61. PubMed ID: 22672818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Factors of Tumor Recurrence and Survival in Patients with Hepatocellular Carcinoma treated with Transarterial Chemoembolization.
    Cerban R; Ester C; Iacob S; Grasu M; Pâslaru L; Dumitru R; Lupescu I; Constantin G; Croitoru A; Gheorghe L
    J Gastrointestin Liver Dis; 2018 Dec; 27(4):409-417. PubMed ID: 30574623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.